Page last updated: 2024-11-06

prednisolone and Lichen Sclerosus et Atrophicus

prednisolone has been researched along with Lichen Sclerosus et Atrophicus in 1 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Lichen Sclerosus et Atrophicus: A chronic inflammatory mucocutaneous disease usually affecting the female genitalia (VULVAR LICHEN SCLEROSUS) and BALANITIS XEROTICA OBLITERANS in males. It is also called white spot disease and Csillag's disease.

Research Excerpts

ExcerptRelevanceReference
"Lichen sclerosus affecting the oral mucosa is extremely rare."1.31Linear oro-facial lichen sclerosus. ( Kanwar, AJ; Kaur, S; Mohan, H; Thami, GP, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaur, S1
Thami, GP1
Kanwar, AJ1
Mohan, H1

Other Studies

1 other study available for prednisolone and Lichen Sclerosus et Atrophicus

ArticleYear
Linear oro-facial lichen sclerosus.
    Clinical and experimental dermatology, 2002, Volume: 27, Issue:6

    Topics: Adolescent; Facial Dermatoses; Follow-Up Studies; Glucocorticoids; Humans; Lichen Sclerosus et Atrop

2002